- Erythema nodosum
-
Erythema nodosum Classification and external resources
Erythema nodosum in a person who had recently had streptococcal pharyngitisICD-10 L52 ICD-9 695.2, 017.1 DiseasesDB 4462 MedlinePlus 000881 eMedicine derm/138 MeSH D004893 Erythema nodosum (EN) (red nodules) is an inflammation of the fat cells under the skin (panniculitis)[1] characterized by tender[2] red nodules[3] or lumps[2] that are usually seen on both shins.[2] EN is an immunologic response to a variety of different causes.
Contents
Classification
Erythema nodosum may be divided into the following types:[4]:488
-
- Acute erythema nodosum
- Chronic erythema nodosum
Signs and symptoms
Erythema nodosum usually resolves itself 3–6 weeks after an event, either internal or external to the body, that initiates a hypersensitivity reaction in subcutaneous fat.[5][6] EN is frequently associated with fever, malaise, and joint pain and inflammation. It presents as tender red nodules on the shins that are smooth and shiny. The nodules may occur anywhere there is fat under the skin, including the thighs, arms, trunk, face, and neck.[7][8] The nodules are 1–10 cm in diameter, and individual nodules may coalesce to form large areas of hardened skin.
As the nodules age, they become bluish purple, brownish, yellowish, and finally green, similar to the color changes that occur in a resolving bruise. The nodules usually subside over a period of 2–6 weeks without ulceration or scarring.[9]
Dermatophytids are similar skin lesions that result from a fungus infection such as ringworm in another area of the body.
Causes
In about 30-50% of cases, the cause of EN is unknown.[10] EN may be associated with a wide variety of diseases, including infections (e.g., hepatitis C, tuberculosis, streptococcal, Mycoplasma pneumoniae, Yersinia, and Epstein-Barr virus), Coccidioides immitis, sarcoidosis, autoimmune disorders (e.g., Inflammatory bowel disease or Behçet's disease), pregnancy, medications (sulfonamides, oral contraceptives, bromides), and cancer.[10][11][12][13] EN may also be due to excessive antibody production in lepromatous leprosy leading to deposition of immune complexes.[14] There is an association with the HLA-B27 histocompatibility antigen, which is present in 65% of patients with erythma nodosum.[15]
Diagnosis
Diagnosis is clinical. A deep punch biopsy or an incisional biopsy may be performed in cases where the diagnosis is unclear. Microscopic examination will reveal a septal panniculitis with acute and chronic inflammation in the fat and around blood vessels.[9]
Once EN is diagnosed, additional evaluation needs to be performed to determine the underlying cause. A complete blood count, erythrocyte sedimentation rate (ESR), antistreptolysin-O (ASO) titer, urinalysis, throat culture, intradermal tuberculin test, and chest x-ray are part of the initial examination.[16]
The ESR is initially very high, and falls as the nodules fade. The ASO titer is high in cases associated with a streptococcal throat infection. A chest X-ray should be performed to rule out pulmonary diseases. Hilar lymphadenopathy may be due to tuberculosis, sarcoidosis, or Löfgren syndrome (a form of acute sarcoidosis with erythema nodosum, bilateral hilar adenopathy, fever and often accompanied by joint symptoms).
Treatment
Erythema nodosum is self limiting and usually resolves itself within 3–6 weeks. A recurring form does exist, and in children it is attributed to repeated infections with streptococcus.[14] Treatment should focus on the underlying cause. Symptoms can be treated with bedrest, leg elevation, compressive bandages, wet dressings, and nonsteroidal anti-inflammatory agents (NSAIDs).[9] NSAIDs are usually more effective at the onset of EN versus with chronic disease.
Potassium iodide can be used for persistent lesions whose cause remains unknown. Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] Thalidomide has been used successfully in the treatment of Erythema nodosum leprosum,[20] and it was approved by the U.S. FDA for this use in July 1998.[21]
Epidemiology
Erythema nodosum is the most common form of panniculitis (inflammation of the subcutaneous fat). The peak incidence of EN occurs between 18–36 years of age. Women are 3-6 times more affected than men.[9]
References
- ^ Richard P. J. B. Weller; J. A. A. Hunter; Mark Dahl (21 March 2008). Clinical Dermatology. John Wiley and Sons. pp. 112–. ISBN 9781405146630. http://books.google.com/?id=5RHM0Nerk9gC&pg=PA112. Retrieved 8 May 2010.
- ^ a b c thefreedictionary.com > erythema nodosum Citing: Gale Encyclopedia of Medicine. 2008 The Gale Group
- ^ "MerckMedicus : Dorland's Medical Dictionary". http://merckmedicus.com/pp/us/hcp/thcp_dorlands_content_split.jsp?pg=/ppdocs/us/common/dorlands/drlnd/three_08/000036718.htm#000036718. Retrieved 2009-02-26.
- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- ^ Ryan TJ (1998). "Cutaneous vasculitis". In Burns DA, Breathnach SM. Textbook of Dermatology (6th ed.). London: Blackwell Science Ltd. pp. 2155–225. ISBN 0-632-05064-0.
- ^ Camilleri MJ, Su WPD (2003). "Panniculitis". In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's Dermatology In General Medicine (6th ed.). New York, NY: McGraw-Hill. ISBN 0-07-138076-0.
- ^ Cribier B, Caille A, Heid E, Grosshans E (1998). "Erythema nodosum and associated diseases. A study of 129 cases". Int J Dermatol 37 (9): 667–72. doi:10.1046/j.1365-4362.1998.00316.x. PMID 9762816.
- ^ White WL, Hitchcock MG (1999). "Diagnosis: erythema nodosum or not?". Semin Cutan Med Surg 18 (1): 47–55. doi:10.1016/S1085-5629(99)80008-X. PMID 10188842.
- ^ a b c d Wolff K, Johnson RA, Suurmond R (2005). "Section 7: Miscellaneous inflammatory disorders". Fitzpatrick's Color Atlas & Synopsis of Clinical Dermatology (5th ed.). New York, NY: McGraw-Hill Professional. ISBN 0-07-144019-4.
- ^ a b Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R (2004). "Erythema nodosum: an experience of 10 years". Scand J Infect Dis 36 (6–7): 424–7. doi:10.1080/00365540410027184. PMID 15307561.
- ^ Anan T, Imamura T, Yokoyama S, Fujiwara S (2004). "Erythema nodosum and granulomatous lesions preceding acute myelomonocytic leukemia". J Dermatol 31 (9): 741–7. PMID 15628321.
- ^ Bohn S, Buchner S, Itin P (1997). "[Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology]". Schweiz Med Wochenschr 127 (27–28): 1168–76. PMID 9324739.
- ^ Lin JT, Chen PM, Huang DF, Kwang WK, Lo K, Wang WS (2004). "Erythema nodosum associated with carcinoid tumour". Clin Exp Dermatol 29 (4): 426–7. doi:10.1111/j.1365-2230.2004.01544.x. PMID 15245549.
- ^ a b Kumar V, Abbas A (2009). Robbins and Coltran Pathological Basis of Disease. pp. 372–373.
- ^ Cunha, Burke. "Infections Disease Pearls" (1999), pp. 105
- ^ Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, Lopez-Lazaro L, Lueiro M, Fernandez ML, Alvarez-Ferreira J, Pujol RM (2000). "Erythema nodosum: etiologic and predictive factors in a defined population". Arthritis Rheum 43 (3): 584–92. doi:10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6. PMID 10728752.
- ^ Mat C, Yurdakul S, Uysal S, Gogus F, Ozyazgan Y, Uysal O, Fresko I, Yazici H (2005). "A double-blind trial of depot corticosteroids in Behcet's syndrome". Rheumatology (Oxford) 45 (3): 348. doi:10.1093/rheumatology/kei165. PMID 16263779.
- ^ Wallace SL (1967). "Erythema nodosum treatment with colchicine". JAMA 202 (11): 1056. doi:10.1001/jama.202.11.1056b. PMID 6072607.
- ^ Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H (2001). "A double-blind trial of colchicine in Behcet's syndrome". Arthritis Rheum 44 (11): 2686–92. doi:10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H. PMID 11710724.
- ^ Silverman WA (August 2002). "The schizophrenic career of a "monster drug"". Pediatrics 110 (2 Pt 1): 404–6. doi:10.1542/peds.110.2.404. PMID 12165600.
- ^ Rouhi, Maureen. "Thalidomide". Chemical & Engineering News. American Chemical Society. http://pubs.acs.org/cen/coverstory/83/8325/8325thalidomide.html. Retrieved 2006-09-21.
Urticaria and erythema (L50–L54, 695, 708) Urticaria
(acute/chronic)Allergic urticariaUrticarial allergic eruptionPhysical urticariaCold urticaria (Familial) · Primary cold contact urticaria · Secondary cold contact urticaria · Reflex cold urticariaVibratory angioedema · Pressure urticariaAquagenic urticariaOther urticariaAcquired C1 esterase inhibitor deficiency · Adrenergic urticaria · Exercise urticaria · Galvanic urticaria · Schnitzler syndrome · Urticaria-like follicular mucinosisEpisodic angioedema with eosinophilia · Hereditary angioedemaErythema Erythema multiforme minor · Erythema multiforme major (Stevens–Johnson syndrome, Toxic epidermal necrolysis) · panniculitis (Erythema nodosum) · Acute generalized exanthematous pustulosisFigurate erythemaOther erythemaNecrolytic migratory erythema · Erythema toxicum · Erythroderma · Palmar erythema · Generalized erythemaDisorders of subcutaneous fat (M79.3, 729.3) Panniculitis Lobularwithout vasculitis: Cytophagic histiocytic panniculitis · Factitial panniculitis · Gouty panniculitis · Pancreatic panniculitis · Traumatic panniculitis (Cold panniculitis) · needle-shaped clefts (Subcutaneous fat necrosis of the newborn, Sclerema neonatorum, Post-steroid panniculitis) · Lipodermatosclerosis · Weber–Christian disease · Lupus erythematosus panniculitis · Sclerosing lipogranulomawith vasculitis: Nodular vasculitis/Erythema induratumSeptalwithout vasculitis: Alpha-1 antitrypsin deficiency panniculitis · Erythema nodosum (Acute erythema nodosum, Chronic erythema nodosum)with vasculitis: Superficial thrombophlebitisLipodystrophy Acquiredgeneralized: Acquired generalized lipodystrophy
partial: Acquired partial lipodystrophy · Centrifugal abdominal lipodystrophy · HIV-associated lipodystrophy · Lipoatrophia annularis
localized: Localized lipodystrophyCongenitalCongenital generalized lipodystrophy · Familial partial lipodystrophy
Poland's syndromeCategories:- Autoimmune diseases
- Erythemas
- Reactive neutrophilic cutaneous conditions
- Conditions of the subcutaneous fat
-
Wikimedia Foundation. 2010.